Annaida Technologies

Medical Devices & EquipmentSeedLausanne, Switzerlandannaida.ch

Latest round

Seed

Last raised

Mar 2020

Total raised

$1M

Investors

6

About Annaida Technologies

Founded in 2019 and based in Lausanne, Switzerland, Annaida Technologies SA is a health technology company focused on the development of human embryo assays through metabolic non-invasive screening to support drug development studies. The company was co-founded by its CEO, Marco Grisi, and others. The company’s primary product includes EmbryoSpin, which that utilizes micro-magnetic resonance spectroscopy (MRS) to offer insights into cellular metabolism, applicable from embryos to stem-cell organoids. This device enhances research in toxicology, drug discovery, and life sciences by providing detailed metabolic profiling without compromising cellular integrity. EmbryoSpin's technology is beneficial for fertility clinics, improving embryo selection and boosting outcomes in Assisted Reproductive Therapy (ART).

Who invested in Annaida Technologies

6 investors across 1 round

See all investors in Annaida Technologies

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Mar 31, 2020

    Amount

    $1M

    Investors

    Locked

Questions about Annaida Technologies

Who invested in Annaida Technologies?

Annaida Technologies has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Annaida Technologies raised?

Annaida Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Annaida Technologies last raise money?

Annaida Technologies's most recent round on record is a Seed, in Mar 2020.

What does Annaida Technologies do?

Founded in 2019 and based in Lausanne, Switzerland, Annaida Technologies SA is a health technology company focused on the development of human embryo assays through metabolic non-invasive screening to support drug development studies.

Where is Annaida Technologies headquartered?

Annaida Technologies is headquartered in Lausanne, Switzerland.

Which VCs invest in companies like Annaida Technologies?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Annaida Technologies's stage. Their profiles are linked below.

Raising like Annaida Technologies? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.